Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling-Reference-Cited by-同舟云学术

Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling

Published:2015-10-26 Issue:41 Volume:6 Page:43375-43394
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Brandolini Laura¹,Cristiano Loredana²,Fidoamore Alessia²,De Pizzol Maria³,Di Giacomo Erica²,Florio Tiziana Marilena²⁴,Confalone Giuseppina²,Galante Angelo²⁴,Cinque Benedetta²,Benedetti Elisabetta²,Ruffini Pier Adelchi³,Cifone Maria Grazia²,Giordano Antonio⁵⁶,Alecci Marcello²⁴,Allegretti Marcello¹,Cimini Annamaria²⁴⁶

Affiliation:

1. Dompé Farmaceutici SpA, Via Campo di Pile, L'Aquila, Italy

2. Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy

3. Dompé Farmaceutici SpA, Via Santa Lucia, Milano, Italy

4. National Institute for Nuclear Physics (INFN), Gran Sasso National Laboratory (LNGS), Assergi, Italy

5. Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy

6. Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Temple University, Philadelphia, PA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D Bioprinted Tumor-Stroma Models of Triple-Negative Breast Cancer Stem Cells for Preclinical Targeted Therapy Evaluation;ACS Applied Materials & Interfaces;2024-05-20

2. Cx₁Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2024-04-01

3. Clinical significance of baseline and post-treatment CXCR1 expression in breast cancer women received neoadjuvant chemotherapy;Journal of the Pakistan Medical Association;2023-05-25

4. Relation between baseline CXCR1 expression and neoadjuvant chemotherapy response in breast cancer patients;Journal of the Pakistan Medical Association;2023-05-25

5. Growth and invasion inhibition of T47D ductal carcinoma cells by the association of docetaxel with a bioactive agent in neutral nanosuspension;BioImpacts;2023-03-01